IFNAR1 and Zika virus infectious disease: Thus, we treated Rag1−/− mice, which are deficient in T- and B-cells [34], with anti-IFNAR1 blocking antibody that inhibits signaling through the IFN-α/β receptor (subsequently called AIR mice) to reduce their resistance to ZIKV infection.